Cookies are important to the proper functioning of the site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored to your interest. By continuing to use this site you are giving us your consent to do this. For more information you can read our Privacy Policy.

Are you a citizen of the United States?

Fujifilm's Response to the COVID-19 Pandemic

Fujifilm's Response
the COVID-19 Pandemic

With the collective goal of enhancing society through innovation, the Fujifilm family is committed to leveraging its resources, talent and technologies to support global efforts to counter the COVID-19 pandemic.

Our sincere gratitude and respect go out to all the healthcare professionals that are working to save lives and aid in the prevention of COVID-19. To help improve patient outcomes throughout the care spectrum, Fujifilm applauds clinicians that are on the front lines treating patients on a daily basis.

During this time, our number one priority remains the health and safety of our customers, workforce and the broader community. In response to the pandemic, we’ve adapted our business practices in order to safeguard our staff, as well as continue to serve our customers, many of which are powering critical operations in the fields of healthcare, technology and media.

As a total healthcare company involved in Prevention, Diagnosis and Treatment, we are committed to supporting the brave clinicians caring for COVID-19 patients with our technologies.

  • Prevention:

    To aid in prevention, we stand ready to support the manufacture of vaccines with world-class biologics production facilities and technical expertise.

  • Diagnosis:

    In the field of diagnosis, our efforts include the provision of a gene-testing research tool which lessens the time required for polymerase chain reaction (PCR) testing i. Our point-of-care imaging equipment such as ultrasound and mobile X-ray systems are playing a vital role in the clinical care process of patients with COVID-19.

  • Treatment:

    Our work in the treatment field includes clinical trials in Japan and the U.S. to evaluate the safety and efficacy of our influenza antiviral drug Avigan® Tablet for patients with COVID-19. In addition, we are providing critical support and manufacturing expertise to support the race toward potential therapies.

Through collaboration, technology and our collective expertise, we will continue to work towards improving human health and helping bring the pandemic to an end.


Available only in Japan and not available for sale in other country/regions

The antiviral drug
Avigan® Tablet
used to treat influenza

Actions taken by the Fujifilm Group

FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax
to manufacture COVID-19 vaccine candidate at its UK site

News release

FUJIFILM Diosynth Biotechnologies will manufacture antigen component of Novavax’ COVID-19 vaccine candidate at its site in Billingham, UK, from beginning of Q1, 2021.

FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing

News release

FUJIFILM Diosynth Biotechnologies Texas Facility will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed.

Novavax and FUJIFILM Diosynth Biotechnologies initiate large-scale manufacturing of COVID-19 vaccine candidate

News release

Novavax, Inc. and FUJIFILM Diosynth Biotechnologies have announced an agreement to manufacture bulk drug substance for Novavax’ COVID-19 vaccine candidate.

FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator

News release

FUJIFILM Diosynth Biotechnologies will reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies for the COVID-19 Therapeutics Accelerator.

FUJIFILM Irvine Scientific, Inc.’s Response to COVID-19

FUJIFILM Irvine Scientific, Inc. supplies cell culture media, which are critical raw materials used for the development of COVID-19 therapies and vaccines, to pharmaceutical companies and research laboratories. The company is also offering free replacement of expired IVF culture media for IVF clinics that have been forced to suspend cycles due to COVID-19 outbreak.

Launch of AI-based technologies development to support diagnosis of COVID-19 pneumonia

News release

Fujifilm has begun development of AI-based technologies that support diagnosis and treatment assesement of COVID-19 pneumonia by for example, evaluating the distribution and progression of lesions within the lung field, and judging therapeutic effectiveness of medicines.

FUJIFILM (Thailand)Ltd. and Thammasat University Hospital revealed the FDR nano. (First installation in Thailand)


For professional healthcare workers

FUJIFILM (Thailand)Ltd. and Thammasat University Hospital revealed the FDR nano, a digital portable X-ray device, equipped with a new type image processing kit to facilitate diagnosis for COVID-19 patients with less time-consuming. (First installation in Thailand)

FUJIFILM Italia strengthens the sub-intensive therapy of ASST in Crema, with 15 new technological beds dedicated to the Covid-19 patient

News release


FUJIFILM Italia S.p.A. donated 15 new technological beds for sub-intensive therapy of ASST Crema Hospital in Italy

“Never Stop” Philosophy Guides Fujifilm in Helping Produce Face Shields for COVID-19 Response


Employees at the FUJIFILM Dimatix, Inc. , Lebanon New Hampshire facility are assembling and shipping protective face shields for their local health system and other hospitals in the region during the pandemic.

Support for the measures to combat novel coronavirus in China

News release


Donation of equipment and materials worth approx. 7 million Chinese Renminbi (approx. JPY110 million, or US$1.1 million) to support the measures to combat novel coronavirus in China. These included medical diagnostic devices that support clinical testing of pneumonia providfed by Fujifilm, and printers for on-site use in medical treatment facilities supplied by Fuji Xerox Co.

Read more